Researchers demonstrated that DNA methyltransferase 3A (DNMT3AR882H)-dependent clonal hematopoiesis and acute myeloid leukemia cells are specifically susceptible to the hypomethylating agent azacytidine.
[Nature Cancer]
Sorry, but the selected Zotpress account can't be found.